Cushing Asset Management, LP Cytosorbents Corp Transaction History

Cushing Asset Management, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.22 $79,358 - $145,189	-45,090 Reduced 79.73%	11,464 $25,000
Q1 2022 May 16, 2022	BUY	$2.88 - $4.23 $109,103 - $160,245	37,883 Added 202.9%	56,554 $180,000
Q4 2021 Feb 14, 2022	SELL	$4.05 - $8.11 $413,942 - $828,906	-102,208 Reduced 84.55%	18,671 $78,000
Q3 2021 Nov 15, 2021	BUY	$7.0 - $9.71 $11,886 - $16,487	1,698 Added 1.42%	120,879 $982,000
Q2 2021 Aug 16, 2021	SELL	$7.55 - $9.42 $8,410 - $10,493	-1,114 Reduced 0.93%	119,181 $900,000

Q1 2021 May 17, 2021	BUY	$8.23 - $11.48 $204,490 - $285,243	24,847 Added 26.03%	120,295 $1.04 Million
Q4 2020 Feb 16, 2021	BUY	$7.65 - $8.98 $263,427 - $309,226	34,435 Added 56.44%	95,448 $761,000
Q3 2020 Nov 16, 2020	BUY	$7.37 - $11.54 $315,421 - $493,888	42,798 Added 234.96%	61,013 $487,000
Q2 2020 Aug 14, 2020	BUY	$6.28 - $10.59 $51,489 - $86,827	8,199 Added 81.86%	18,215 $180,000
Q1 2020 May 15, 2020	SELL	$3.77 - $7.73 $27,701 - $56,800	-7,348 Reduced 42.32%	10,016 $77,000
Q4 2019 Feb 14, 2020	SELL	$3.61 - $5.22 $193,059 - $279,160	-53,479 Reduced 75.49%	17,364 $67,000
Q3 2019 Nov 14, 2019	BUY	$4.33 - $7.63 $306,750 - $540,532	70,843 New	70,843 $356,000

17.8M

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $39.7M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Cushing Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cushing Asset Management, LP with notifications on news.